| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/03009747309097109 |
| P953 | full work available at URL | http://www.tandfonline.com/doi/pdf/10.3109/03009747309097109 |
| P698 | PubMed publication ID | 4590034 |
| P2093 | author name string | W. Strauss | |
| A. Lussier | |||
| G. Boost | |||
| E. Segre | |||
| J. Varady | |||
| D. Myhal | |||
| P2860 | cites work | Raised serum alkaline phosphatase in rheumatoid disease. An index of liver dysfunction? | Q33580118 |
| Naproxen: A novel approach to dose-flnding efficacy trials in rheumatoid arthritis | Q69254111 | ||
| Assessment of Drug Efficacy in Rheumatoid Arthritis | Q69916487 | ||
| The estimation of inflammatory activity in rheumatoid arthritis. Role of composite indices | Q72207443 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunology | Q101929 |
| rheumatology | Q327657 | ||
| placebo | Q269829 | ||
| naproxen | Q1215575 | ||
| P304 | page(s) | 113-120 | |
| P577 | publication date | 1973-01-01 | |
| P1433 | published in | Scandinavian journal of rheumatology. Supplement | Q27713383 |
| P1476 | title | Long term study of naproxen challenged by a short-term double blind cross-over study with placebo in rheumatoid patients | |
| Long Term Study of Naproxen Challenged by a Short-Term Double Blind Cross-Over Study with Placebo in Rheumatoid Patients | |||
| P478 | volume | 2 |
| Q93499047 | Clinical evaluation of two daily doses of naproxen and indomethacin: result of a double-blind crossover trial |
| Q40862528 | Naproxen in the Treatment of Juvenile Rheumatoid Arthritis: Metabolism, safety and efficacy |
| Q39812206 | Naproxen up to date: a review of its pharmacological properties and therapeutic efficacy and use in rheumatic diseases and pain states |
| Q34022850 | Naproxen: a review of its pharmacological properties and therapeutic efficacy and use. |
| Q38335274 | Patients' preference in indomethacin trials: an overview |
Search more.